Skip to main content

HDL Cholesterol May Protect Against Brain Atrophy

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 7, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 7, 2025 -- High-density lipoprotein (HDL) cholesterol may help conserve healthy brain matter in middle-aged adults, according to a study published online Oct. 18 in the Journal of Clinical Medicine.

John M. Giacona, Ph.D., from University of Texas Southwestern Medical Center in Dallas, and colleagues examined associations between HDL measures and brain structure and function. The analysis included data from 1,826 adult participants (47 percent Black; mean age, 51.0 years) in the Dallas Heart Study.

The researchers found that higher HDL cholesterol efflux capacity and small HDL particle (HDL-P) concentration were positively associated with higher whole-brain grey matter volume normalized to total cranial volume (GMV/TCV) when adjusting for traditional risk factors such as age, smoking status, time spent in daily physical activity, and education level (β = 0.078 and 0.063, respectively). There were no associations between HDL measures and white matter hyperintensities or Montreal Cognitive Assessment scores. These associations between HDL cholesterol efflux capacity and small HDL-P with GMV/TCV were not modified by apolipoprotein E-ε4 status or race/ethnicity.

"Having higher GMV in midlife may aid in preventing cognitive decline associated with brain atrophy as part of normal aging in late life," the authors write. "Additional studies are needed to explore the potential neuroprotective functions of HDL."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...

32 Percent of Dementia Attributed to Audiometric Hearing Loss

MONDAY, April 28, 2025 -- The population attributable fraction of dementia from any audiometric hearing loss is 32.0 percent, according to a study published online April 17 in...

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

MONDAY, April 28, 2025 -- For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial, according to a study published online in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.